CD8A and neoplasm: Clearly, this combination did not lead to a significant change in the number of tumor-infiltrating CD8+ cells in either MOC2 tumors or TC-1 tumors (Supplementary Fig. S4), suggesting that αIL6 and RS504393 alone or their combination primarily act on NK cells in the TME.